Literature DB >> 17915091

Undifferentiated spondyloarthritis: a global perspective.

Rubén Burgos-Vargas1.   

Abstract

This paper reviews the concept and outcome of undifferentiated spondyloarthritis (SpA) as reported in retrospective and prospective studies from different parts of the world. Although the designs and definitions vary across different studies, clearly a significant proportion of patients with undifferentiated SpA will fulfill ankylosing spondylitis within 10 years in association with certain prognostic factors. The paper also examines the concept of axial SpA and its importance as an early indicator of ankylosing spondylitis. Ultimately, the recognition of undifferentiated SpA and axial SpA may lead to early treatment with highly efficacious drugs.

Entities:  

Mesh：

Year:  2007        PMID： 17915091     DOI： 10.1007/s11926-007-0058-2

Source DB:  PubMed          Journal:  Curr Rheumatol Rep        ISSN： 1523-3774            Impact factor:   4.592


  57 in total

1.  Repeated infusions of infliximab, a chimeric anti-TNFalpha monoclonal antibody, in patients with active spondyloarthropathy: one year follow up.

Authors:  E Kruithof; F Van den Bosch; D Baeten; A Herssens; F De Keyser; H Mielants; E M Veys
Journal:  Ann Rheum Dis       Date:  2002-03       Impact factor: 19.103

2.  Effects of a loading dose regimen of three infusions of chimeric monoclonal antibody to tumour necrosis factor alpha (infliximab) in spondyloarthropathy: an open pilot study.

Authors:  F Van den Bosch; E Kruithof; D Baeten; F De Keyser; H Mielants; E M Veys
Journal:  Ann Rheum Dis       Date:  2000-06       Impact factor: 19.103

Review 3.  Anti-tumour necrosis factor (TNF)-alpha therapy in undifferentiated spondyloarthropathy.

Authors:  S Schnarr; J G Kuipers; H Zeidler
Journal:  Clin Exp Rheumatol       Date:  2002 Nov-Dec       Impact factor: 4.473

4.  Natural course and prognosis of HLA-B27-positive oligoarthritis.

Authors:  M Schattenkirchner; K Krüger
Journal:  Clin Rheumatol       Date:  1987-09       Impact factor: 2.980

5.  Impaired Th1 cytokine production in spondyloarthropathy is restored by anti-TNFalpha.

Authors:  D Baeten; N Van Damme; F Van den Bosch; E Kruithof; M De Vos; H Mielants; E M Veys; F De Keyser
Journal:  Ann Rheum Dis       Date:  2001-08       Impact factor: 19.103

6.  Spondyloarthropathy in the community: clinical syndromes and disease manifestations in Alaskan Eskimo populations.

Authors:  G S Boyer; D W Templin; A Bowler; R C Lawrence; S P Heyse; D F Everett; J C Cornoni-Huntley
Journal:  J Rheumatol       Date:  1999-07       Impact factor: 4.666

7.  How to diagnose axial spondyloarthritis early.

Authors:  M Rudwaleit; D van der Heijde; M A Khan; J Braun; J Sieper
Journal:  Ann Rheum Dis       Date:  2004-05       Impact factor: 19.103

8.  Performance of referral recommendations in patients with chronic back pain and suspected axial spondyloarthritis.

Authors:  Henning Christian Brandt; Inge Spiller; In-Ho Song; Janis L Vahldiek; Martin Rudwaleit; Joachim Sieper
Journal:  Ann Rheum Dis       Date:  2007-04-24       Impact factor: 19.103

9.  Doxycycline versus doxycycline and rifampin in undifferentiated spondyloarthropathy, with special reference to chlamydia-induced arthritis. A prospective, randomized 9-month comparison.

Authors:  John D Carter; Joanne Valeriano; Frank B Vasey
Journal:  J Rheumatol       Date:  2004-10       Impact factor: 4.666

10.  The early clinical recognition of juvenile-onset ankylosing spondylitis and its differentiation from juvenile rheumatoid arthritis.

Authors:  R Burgos-Vargas; J Vázquez-Mellado
Journal:  Arthritis Rheum       Date:  1995-06
View more
  5 in total

1.  The assessment of the spondyloarthritis international society concept and criteria for the classification of axial spondyloarthritis and peripheral spondyloarthritis: A critical appraisal for the pediatric rheumatologist.

Authors:  Ruben Burgos-Vargas
Journal:  Pediatr Rheumatol Online J       Date:  2012-05-31       Impact factor: 3.054

2.  Atlantoaxial subluxation as an early manifestation in an adolescent with undifferentiated spondyloarthritis: a case report and review of the literature.

Authors:  Eyal Muscal; Krishna B Satyan; Andrew Jea
Journal:  J Med Case Rep       Date:  2011-07-03

Review 3.  Progression rate of ankylosing spondylitis in patients with undifferentiated spondyloarthritis: A systematic review and meta-analysis.

Authors:  Qing Xia; Dazhi Fan; Xiao Yang; Xiaona Li; Xu Zhang; Mengmeng Wang; Shengqian Xu; Faming Pan
Journal:  Medicine (Baltimore)       Date:  2017-01       Impact factor: 1.889

4.  Higher Levels of Secretory IgA Are Associated with Low Disease Activity Index in Patients with Reactive Arthritis and Undifferentiated Spondyloarthritis.

Authors:  Fabián Salas-Cuestas; Wilson Bautista-Molano; Juan M Bello-Gualtero; Ivonne Arias; Diana Marcela Castillo; Lorena Chila-Moreno; Rafael Valle-Oñate; Daniel Herrera; Consuelo Romero-Sánchez
Journal:  Front Immunol       Date:  2017-04-27       Impact factor: 7.561

5.  Prevalence of chronic widespread pain in a population-based cohort of patients with spondyloarthritis - a cross-sectional study.

Authors:  Elisabeth Mogard; Ann Bremander; Elisabet Lindqvist; Stefan Bergman
Journal:  BMC Rheumatol       Date:  2018-04-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.